Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

June 23, 2011

Carlsson, A., Wingren, C., Kristensson, M., Fernö, M., Olsson, H., Peterson, C., Borrebaeck, CAK.  Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 14252-7.